Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01209884 · ClinicalTrials.gov registry record
Metabolomics of Aging: Sub-study of the Healthy Elderly Active Longevity (HEAL) Study
A clinical trial, sponsored by Scripps Translational Science Institute.
- Completed
- Registry status
- 14
- Enrollment target
NCT01209884 is a clinical trial that has completed, run by Scripps Translational Science Institute. The registered enrollment target is 14 participants.
The verdict
NCT01209884 has completed, sponsored by Scripps Translational Science Institute.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
This research is being done to learn more about healthy aging. We hope to learn which bodily processes or functions are important for the elderly to maintain good health. Metabolites (for example, glucose) are small molecules in our bodies that are used in all bodily reactions. Looking at their levels in healthy elderly people may help researchers find out which processes lead some people to get to disease and others to not. Metabolites are the basic building blocks for people. They are used to construct larger complexes(such as proteins), relay signals from one part of the body to another, and as a source of energy. While most people have essentially the same types of metabolites, the relative levels of these metabolites vary from one individual to another. These levels reflect the body's state of growth, development, and reproduction. An appropriate balance in metabolites is important to maintaining general health. Conditions like cancer and diabetes result in disrupted levels of metabolites that are associated with changes in bodily functions. Deviations from normal levels of metabolites can be used as a signature for disease. Researchers have discovered that a disruption in unique metabolite levels is associated with human aging. In this study we hope to learn which, if any, of these disruptions are associated with the onset of age-related disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01209884
The ClinicalTrials.gov registry entry for NCT01209884 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scripps Translational Science Institute, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01209884 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01209884 about?
NCT01209884 is a clinical study titled "Metabolomics of Aging: Sub-study of the Healthy Elderly Active Longevity (HEAL) Study". This research is being done to learn more about healthy aging. We hope to learn which bodily processes or functions are important for the elderly to maintain good health. Metabolites (for example, glucose) are small molecules in our bodies that are used in all bodily reactions. Looking at their leve...
What is the current status of trial NCT01209884?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2010-02. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT01209884?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.